Nevertheless, our animal data is consistent with several clinical reports demonstrating that TdP is not frequent in COVID-19 patients and that more in general in the setting of inflammation, IL-6 is a potential additional non-conventional risk factor for the development of cardiac arrhythmias alone or in combination with antimalarial or antibiotic drugs. The gene discussed is IL6; the disease is COVID-19.